Darren Hauck/Getty Images

Associate research specialist at the Wisconsin National Primate Research Center at University Wisconsin-Madison removes a new batch of Embryonic Stem Cells from deep freeze to be thawed before being worked on.

Today – biotech company Geron announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells. The company will be injecting the cells directly onto injured spinal cords with the hope that the cells will re-grow damaged connections and help paralyzed patients regain at least some movement. Where does congress stand on stem cells today and what does that mean for Geron?

Guest:

Alan Trounson, President of the California Institute of Regenerative Medicine